SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000942
Filing Date
2021-08-05
Accepted
2021-08-05 16:24:23
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q harp-20210630.htm   iXBRL 10-Q 2917600
2 EX-31.1 harp-20210630ex31_1.htm EX-31.1 12895
3 EX-31.2 harp-20210630ex31_2.htm EX-31.2 12879
4 EX-32.1 harp-20210630ex32_1.htm EX-32.1 9856
  Complete submission text file 0000950170-21-000942.txt   9596417

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20210630.xsd EX-101.SCH 48255
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT harp-20210630_def.xml EX-101.DEF 164177
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20210630_pre.xml EX-101.PRE 284667
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT harp-20210630_cal.xml EX-101.CAL 42502
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20210630_lab.xml EX-101.LAB 394994
10 EXTRACTED XBRL INSTANCE DOCUMENT harp-20210630_htm.xml XML 2043663
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 211148642
SIC: 2836 Biological Products, (No Diagnostic Substances)